COVID-19 and MS disease-modifying therapies

OBJECTIVE: To address concerns regarding the effect of MS disease-modifying therapies (DMTs) on the expression of coronavirus 2019 (COVID-19). METHODS: Review of the current state of knowledge regarding the viral etiology of COVID-19, mechanisms of injury by SARS-CoV-2 infection, and the effect of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Joseph R., Brandstadter, Rachel, Bar-Or, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238896/
https://www.ncbi.nlm.nih.gov/pubmed/32414755
http://dx.doi.org/10.1212/NXI.0000000000000761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238896/
https://www.ncbi.nlm.nih.gov/pubmed/32414755
http://dx.doi.org/10.1212/NXI.0000000000000761

Ejemplares similares